Search results
Results from the WOW.Com Content Network
Biochimica et Biophysica Acta was first published in 1947 and was the first international journal to be devoted to the joint fields of biochemistry and biophysics. [1] Published by Elsevier in cooperation with Interscience, it was the first international journal to be launched by Elsevier. [1] The journal first made a profit in 1951. [1]
Acta Biochimica et Biophysica Sinica was a Chinese-language journal entitled "Shengwu Huaxue Yu Shengwu Wuli Xuebao" (see box below), which began publishing sometime in 1958 or 1959, or August 1961, until December 2003 (depending on the source). Tables of contents were in English.
6697 20751 Ensembl ENSG00000116096 ENSMUSG00000033735 UniProt P35270 Q64105 RefSeq (mRNA) NM_003124 NM_011467 RefSeq (protein) NP_003115 n/a Location (UCSC) Chr 2: 72.89 – 72.89 Mb Chr 6: 85.11 – 85.11 Mb PubMed search Wikidata View/Edit Human View/Edit Mouse Sepiapterin reductase is an enzyme that in humans is encoded by the SPR gene. Function Sepiapterin reductase (7,8-dihydrobiopterin ...
From an ISO 4 abbreviation: This is a redirect from an ISO 4 publication title abbreviation to the unabbreviated publication title, or an article containing information about the publication. In cases of an ISO 4 abbreviation with partially missing dots, or dots used inappropriately, please use {{ R from misspelling }}.
Biochemical and Biophysical Research Communications is a weekly peer-reviewed scientific journal covering all aspects of biochemistry and biophysics.It was established in 1959 by Academic Press and is currently published by Elsevier.
A 54 mg tablet of Concerta, which uses OROS technology. 22% of the drug is contained in the red overcoat, while the remaining 78% is split between two drug layers of differing concentration. The tablet uses an additional push layer that expands as water enters the tablet via the osmotic membrane.
Cefpodoxime has been used to treat gonorrhoea, tonsillitis, pneumonia, and bronchitis. The following minimum inhibitory concentrations have been reported: [2] Haemophilus influenzae: ≤0.03 – 1 μg/ml; Neisseria gonorrhoeae: 0.004 – 0.06 μg/ml; Streptococcus pyogenes: ≤0.004 – 2 μg/ml
Baricitinib is a Janus kinase (JAK) inhibitor that reversibly inhibits Janus kinase 1 with a half maximal inhibitory concentration (IC 50) of 5.9 nM and Janus kinase 2 with an IC 50 of 5.7 nM. Tyrosine kinase 2, which belongs to the same enzyme family, is affected less (IC 50 = 53 nM), and Janus kinase 3 far less (IC 50 > 400 nM).